In celebration of Breast Cancer Awareness Month, Novartis and Healthway Cancer Care Hospital hosted the "Celebrating Strength ...
Novartis (NVS) announced results from an updated analysis of the pivotal Phase 3 NATALEE trial of Kisqali that it says “underscore the extended ...
Siemens Healthineers announced today that it completed the acquisition of Advanced Accelerator Applications Molecular Imaging ...
Reduction in distant recurrence consistently deepened beyond 3-year Kisqali treatment duration in patients with node-positive (N+) and high-risk node-negative (N0) disease, as well as between ...
Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of ...
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing ...
Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...
Longer-term data for Novartis Scemblix reinforce superior efficacy with favourable safety and tolerability profile in adults with newly diagnosed CML: Basel Tuesday, December 10, ...
Oss, The Netherlands-based Citryll, a biotech company, announced on Monday that it has closed an oversubscribed €85M in a ...
GET MORE AI-GENERATED SIGNALS: December 10, 2024, 14:08 pm ET, BY Thomas H. Kee Jr- Editor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Short NVS slightly under 106.24, target ...
A research collaboration between Elysium Health, Inc.â„¢, a leading longevity science company, and the University of Oxford ...
BusinessWire India Mumbai Maharashtra [India] 10 The University of Western Australia UWA is excited to announce its Batch 8 a ...